The Journal of Maternal-Fetal & Neonatal Medicine · 2010 · 22 citations · 20 references
MedicineCardiologyPediatricsNeonatal HealthNeonatologyUltrasonographyCardiac BiomarkersCardiac PhysiologyCardiac UltrasonographyCardiac UltrasoundNeonatal CardiologyNeonatal UltrasonographyAge-specific Reference RangesBiochemical Screening MarkersCreatine Kinase-mbMyocardial Injury DetectionMyocardial Injury MarkersNeonatal Cardiac BiomarkersNeonatal Myocardial FunctionTroponin Elevation
INTRODUCTION: Cardiac ultrasounds (US) are not always available at the bedside. Cardiac Troponin I (cTnI), CK-MB and NT-proBNP may be an alternative or complementary to influence evaluation and treatment. OBJECTIVES: To determine reference ranges of biochemical markers cTnI, CK-MB and NT-proBNP in normal neonates. METHODOLOGY: Cord and blood samples were collected from neonates and the above biochemical markers were determined. Ultrasounds were performed blindly. RESULTS: CK-MB remains constant from cord blood to the first day, declining thereafter to almost half the values (81.5 vs 52.0 U/l); cTnI increases from 0.004 to 0.058 ng/ml by 72 h falling to 0.030 by day 10; NT-proBNP peaks by 24 h (5085.5 pg/ml), subsiding to 3388.5 pg/ml by day 3, falling to 1316.0 pg/ml by day 10. CONCLUSIONS: CK-MB, mostly of muscle origin and reflecting labor stress or injury, is not to recommend as a measure of myocardial damage in the neonate. The rise in cTnI may be explained by a degree of myocardial involvement, albeit physiological. The initial rise and subsequent fall of NT-proBNP represents the physiological ventricular overload of transient birth adaptation.
20
David A. Morrow, Christopher P. Cannon, Robert L. Jesse et al. · Circulation · 2007 · 611 citations
Thomas S. Mir, Reinhard Laux, Hans Henning Hellwege et al. · PEDIATRICS · 2003 · 146 citations